Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J HIRSH

Showing results (291-300 of 666) with videos related to

Pageof 67
Sort By:
The New England Journal of Medicine|December 18, 1975
Platelet-inhibiting drugs in the prevention of clinical thrombotic disease (third of three parts)E Genton, M Gent, J Hirsh, et al.
The Journal of the Acoustical Society of America|August 1, 1970
Pitch of tone bursts of changing frequencyI V Nábĕlek, A K Nábĕlek, I J Hirsh
Thrombosis Research|January 1, 1981
The factor VIII-independent activation of factor X by factors IXa and VII in plasmaF Ofosu, M A Blajchman, G Modi, et al.
Chest|October 1, 1992
Heparin: mechanism of action, pharmacokinetics, dosing considerations, monitoring, efficacy, and safetyJ Hirsh, J E Dalen, D Deykin, et al.
Thrombosis and Haemostasis|May 6, 1991
Standard and low molecular weight heparin have no effect on tissue plasminogen activator induced plasma clot lysis or fibrinogenolysisJ I Weitz, J Kuint, B Leslie, et al.
Journal of Experimental Psychology|March 19, 2010
The difference between monaural and binaural thresholdsW A SHAW, E B NEWMAN, I J HIRSH
Chest|October 1, 1992
Hemorrhagic complications of anticoagulant treatmentM N Levine, J Hirsh, S Landefeld, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|August 1, 1997
Induction of the acute-phase reaction increases heparin-binding proteins in plasmaE Young, T J Podor, T Venner, et al.
Thrombosis Research|December 15, 1985
The thrombolytic and hemorrhagic effects of tissue type plasminogen activator: influence of dosage regimens in rabbitsG Agnelli, M R Buchanan, F Fernandez, et al.
Blood|August 15, 1995
The effects of low molecular weight and standard heparin on calcium loss from fetal rat calvariaS G Shaughnessy, E Young, P Deschamps, et al.
Pageof 67

Showing results (291-300 of 666) with videos related to

Sort By:
Pageof 67
The New England Journal of Medicine|December 18, 1975
Platelet-inhibiting drugs in the prevention of clinical thrombotic disease (third of three parts)E Genton, M Gent, J Hirsh, et al.
The Journal of the Acoustical Society of America|August 1, 1970
Pitch of tone bursts of changing frequencyI V Nábĕlek, A K Nábĕlek, I J Hirsh
Thrombosis Research|January 1, 1981
The factor VIII-independent activation of factor X by factors IXa and VII in plasmaF Ofosu, M A Blajchman, G Modi, et al.
Chest|October 1, 1992
Heparin: mechanism of action, pharmacokinetics, dosing considerations, monitoring, efficacy, and safetyJ Hirsh, J E Dalen, D Deykin, et al.
Thrombosis and Haemostasis|May 6, 1991
Standard and low molecular weight heparin have no effect on tissue plasminogen activator induced plasma clot lysis or fibrinogenolysisJ I Weitz, J Kuint, B Leslie, et al.
Journal of Experimental Psychology|March 19, 2010
The difference between monaural and binaural thresholdsW A SHAW, E B NEWMAN, I J HIRSH
Chest|October 1, 1992
Hemorrhagic complications of anticoagulant treatmentM N Levine, J Hirsh, S Landefeld, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|August 1, 1997
Induction of the acute-phase reaction increases heparin-binding proteins in plasmaE Young, T J Podor, T Venner, et al.
Thrombosis Research|December 15, 1985
The thrombolytic and hemorrhagic effects of tissue type plasminogen activator: influence of dosage regimens in rabbitsG Agnelli, M R Buchanan, F Fernandez, et al.
Blood|August 15, 1995
The effects of low molecular weight and standard heparin on calcium loss from fetal rat calvariaS G Shaughnessy, E Young, P Deschamps, et al.
Pageof 67